NCT04652830 (NapraDRAM) is a NA clinical trial of Naprapathy training in Diastasis Recti, sponsored by Karolinska Institutet.

Who is sponsoring NCT04652830?

NCT04652830 is sponsored by Karolinska Institutet.

What drugs are being tested in NCT04652830?

Interventions in NCT04652830: Naprapathy training, Control group.

What condition does NCT04652830 study?

NCT04652830 studies Diastasis Recti.

Is NCT04652830 still recruiting?

NCT04652830 is currently recruiting now. Last updated 3 January 2025.

Last reviewed 2025-01-03 · How we verify

NCT04652830: NapraDRAM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Naprapathy Training for Postpartum DRAM Prevention

Recruiting now NA Last updated 3 January 2025

What this trial tests

NA trial testing Naprapathy training in Diastasis Recti in 70 participants. Currently enrolling.

Timeline

1 March 2021

Primary endpoint
31 October 2025

31 October 2026

Quick facts

Lead sponsor	Karolinska Institutet
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	70
Start date	1 March 2021
Primary completion	31 October 2025
Estimated completion	31 October 2026
Sites	1 location across Sweden

Drugs / interventions tested

Naprapathy training
Control group — full drug profile →

Conditions studied

Diastasis Recti — all drugs for Diastasis Recti →

Sponsor

Karolinska Institutet

Who can join

Adults 18 to 50, female only, with Diastasis Recti. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomised controlled trial with the aim of analysing the effectiveness of a training program intended to prevent symptoms related to DRAM in the postpartum period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diastasis Recti

Currently open trials in the same condition.

NCT07520409 — Effects of Drawing in Maneuver and Resisted Ankle Dorsiflexion in Postpartum Diastasis Recti · NA · recruiting
NCT07440836 — Effects of Corrective Versus Plank Exercises on Diastasis Recti · NA · recruiting
NCT06723353 — Effects of Visceral Manipulation Combined with Kinesio Taping on Diastasis Recti, Pain Intensity, Stress Incontinence, P · NA · recruiting

Other Karolinska Institutet trials

Trials by the same sponsor.

NCT06359262 — Evaluating the Hope@School Prevention Program · NA · not yet recruiting
NCT07289490 — Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral Hernias · NA · not yet recruiting
NCT06894264 — Emotion Processing and Regulation in People With Intellectual Disability · NA · not yet recruiting
NCT07494266 — Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited · NA · not yet recruiting
NCT07442032 — Cardiovascular Phenotypes in Sepsis · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04652830 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Karolinska Institutet
Last refreshed: 3 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04652830.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing